Topic
5 K-Dense articles on Oncology — research automation, benchmarks, and case studies from the K-Dense team.
K-Dense Web tested all 3,629 TP53 DNA-binding domain missense variants against structure, function and ClinVar, and exposed a circular pathogenicity benchmark.
K-Dense Web analyzed global RAS mutation prevalence, drug eligibility, statistics, and the clinical-trial landscape in pancreatic cancer (PDAC).
K-Dense Web integrated 6 databases, ranked 6 candidate biomarkers, and produced Phase III trial design recommendations for CD20xCD3 bispecifics in DLBCL.
K-Dense Web queried 6 databases, modeled KRAS structure, mapped the tumor microenvironment, and built a 36-slide iNeST strategy for PDAC neoantigen vaccines.
GBM clinical trial analysis: 1,913 trials, yet zero breakthrough approvals. Three insights explain the gap and where glioblastoma research must go next.
By Brian Laffin
